This UK-based resource supports the monitoring and safe use of anti-tuberculosis drugs and second line treatment of MDR-TB. Its guidance team comprises Jessica L. Potter, Toby Capstick, William M. Ricketts, Nuala Whitehead and Onn Min Kon.
All documents can be found via their website here.
Interstitial Lung Disease (ILD) is an umbrella term for lung disorders characterised by tissue...
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...